查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
肾功能检测市场 - 2018-2028 年全球行业规模、份额、趋势、机遇和预测，按类型、组件、最终用户和地区细分
市场调查报告书
商品编码
1221590

肾功能检测市场 - 2018-2028 年全球行业规模、份额、趋势、机遇和预测，按类型、组件、最终用户和地区细分

Kidney Function Tests Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Type, By Component, By End User, By Region
出版日期: | 出版商: TechSci Research | 英文 115 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

全球肾功能检测市场预计到 2022 年将超过 8.62 亿美元，到 2028 年将以 9.71% 的复合年增长率增长。

全球肾功能检测市场的增长预计将受到肾功能诊断技术意识提高的支持。 糖尿病和高血压是导致全球慢性肾脏病负担不断增加的主要原因。 在接下来的几年里，糖尿病患病率上升预计将影响市场扩张。 根据第 10 版国际糖尿病地图集，估计到 2021 年，将有 5.37 亿成年人（20-79 岁）或十分之一患有糖尿病。 预计到 2030 年将增加到 6.43 亿，到 2045 年将增加到 7.83 亿。 肾臟是人体最重要的器官之一。 肾臟充当血液过滤器，从血液中重新吸收必需元素并去除水溶性废物。 因此，如果我们不通过再生死去的肾单位和维持适当的血液循环来维持健康的细胞增殖，我们就更有可能癌变和转移。 肾功能不全在世界范围内很常见，并且其发病率正在迅速增加。 与肾臟相关的症状包括高血压、尿液中的血液、排尿困难、尿频以及由于积液导致的手脚肿胀。

肾臟疾病增加

获得性囊性肾病、淀粉样变性、糖尿病、异位肾病、肾小球疾病、抗GBM（Goodpasture）病和IgA肾病等肾臟疾病的增加需要准确的诊断和适当的治疗。患者数量急剧增加. 预计这将推动全球肾功能检测市场的增长。 此外，急性肾损伤 (AKI)，也称为急性肾功能衰竭或急性肾损伤，是入院患者中非常常见的病症。 急性肾损伤 (AKI) 影响全世界超过 1300 万人，每年导致 170 万人死亡。 预计肾臟疾病和病症发病率的上升将增加对早期诊断和治疗的需求，从而推动市场增长。 例如，根据美国疾病控制和预防中心 (CDC) 的数据，40% 的肾功能严重受损的人并不知道自己患有慢性肾病 (CKD)。

技术进步

在诊断和治疗中越来越多地采用先进技术，预计将推动市场增长。 这些持续的发展和创新为患者提供了更好的治疗。 最新的技术趋势包括基于计算机的智能决策支持系统 (DSS) 和专家系统（用于透析并基于遗传算法和人工神经网络 (ANN)）。 此外，由于对 IoT（物联网）的兴趣日益浓厚，作为浅层 ANN 的扩展且复杂的深度学习正被用于医疗领域。 这些进步在诊断成像、警报系统和诊断辅助方面很有用。

糖尿病和高血压患病率增加

糖尿病和高血压等基础疾病的增加显着增加了对这些慢性病诊断和治疗的需求。 预计这将对全球肾功能检测市场的增长产生积极影响。 根据美国疾病控制与预防中心 (CDC) 的数据，2019 年将有大约 3730 万糖尿病患者，占美国人口的 11.3%。 其中，有 2870 万人确诊，850 万人未确诊。 随着人口老龄化，患糖尿病、高血压等慢性病的风险增加，更容易患上肾病和肾功能衰竭。 由于这些慢性疾病会导致肾臟损害和衰竭，因此患有糖尿病和高血压的老年人越来越多，这增加了对肾功能检查的需求。 此外，糖尿病和高血压患病率的增加正在增加慢性肾病 (CKD) 和急性肾损伤 (AKI) 患者的数量，从而推动市场增长。

近期发展

  • 2019 年，Fresenius Medical Care 凭藉其最先进的血液透析机获得了美国 FDA 的突破性设备称号，该机旨在不使用药物即可停止血液凝固。
  • 同样在 2019 年，CareDx 宣布了一种专为肾移植打造的新模型。 为患有慢性肾脏病 (CKD) 的人配备预测性人工智能 (AI)。
  • 最近，bioMerieux 于 2022 年获得美国食品和药物管理局 (U.S. FDA) 的批准，其创新的 VIDAS NEPHROCHECK 检测方法可检测有急性肾损伤 (AKI) 风险的个体的肾臟压力。底部。

可自定义

TechSci Research 根据市场数据为公司的特定需求提供定制服务。 该报告可以定制为：

公司信息

  • 对其他市场参与者（最多 5 家公司）进行深入分析和概况分析。

内容

第 1 章概述

第2章研究方法论

第 3 章执行摘要

第4章客户反馈

  • 肾臟疾病的流行：性别歧视
  • 肾病患病率（按年龄组划分）
  • 患者对慢性肾病的认识
  • 常见肾臟疾病
  • 进行肾功能检查时常用的物品

第 5 章肾功能检测的全球市场展望

  • 市场规模和预测
    • 按金额
  • 市场份额和预测
    • 按类型（尿液分析、血液测试）
    • 按成分（滴管、试剂、试剂盒和化验、其他）
    • 由最终用户（医院/诊所、诊断室等）
    • 按地区
  • 市场地图
    • 按类型
    • 按组件
    • 最终用户
    • 按地区

第6章北美肾功能检测市场展望

  • 市场规模和预测
    • 按金额
  • 市场份额和预测
    • 按类型
    • 按成分
    • 最终用户
  • 按国家/地区划分的北美市场分析
    • 美国
    • 加拿大
    • 墨西哥

第7章欧洲肾功能检测市场前景

  • 市场规模和预测
    • 按金额
  • 市场份额和预测
    • 按类型
    • 按成分
    • 最终用户
    • 按地区
  • 欧洲国家分析
    • 法国
    • 德国
    • 英国
    • 荷兰
    • 瑞典
    • 意大利
    • 西班牙

第 8 章亚太地区肾功能检测市场展望

  • 市场规模和预测
    • 按金额
  • 市场份额和预测
    • 按类型
    • 按成分
    • 最终用户
    • 按地区
  • 亚太国家/地区分析
    • 中国
    • 日本
    • 新加坡
    • 印度
    • 韩国农业
    • 澳大利亚农业

第9章南美肾功能检测市场展望

  • 市场规模和预测
    • 按金额
  • 市场份额和预测
    • 按类型
    • 按成分
    • 最终用户
    • 按地区
  • 南美分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第 10 章：中东和非洲肾功能测试的市场前景

  • 市场规模和预测
    • 按金额
  • 市场份额和预测
    • 按类型
    • 按成分
    • 最终用户
    • 按地区
  • MEA：国家分析
    • 阿联酋肾功能测试
    • 沙特阿拉伯的肾功能测试
    • 南非的肾功能测试

第 11 章市场动态

  • 司机
    • 肾臟疾病和疾病的患病率上升
    • 技术进步
    • 糖尿病和高血压的增加
  • 任务
    • 严格的监管批准
    • 缺乏意识
    • 虚假识别报告

第12章新兴国家市场趋势与发展

  • 肾臟疾病的家庭诊断测试
  • 增加新的肾臟测试
  • 合作研究的增加

第13章竞争环境竞争格局

  • Business Overview
  • Product Offerings
  • Recent Developments
  • Financials（As Reported）
  • Key Personnel
  • SWOT Analysis
    • Baxter International Inc
    • Abbott Laboratories, Inc.
    • Sysmex Corporation
    • F. Hoffmann-La Roche Ltd
    • Danaher Corporation
    • URIT Medical Electronic Co. Ltd
    • Nova Biomedical Corporation
    • Laboratory Corporation of America Holdings
    • Siemens Healthineers
    • ARKRAY Inc.
    • IDEXX Laboratories, Inc
    • Fresenius SE & Co. KGaA
    • Cook Group
    • ACON Laboratories, Inc.
    • Randox Laboratories Ltd.

第14章 战略建议

Product Code: 4585

Global kidney function tests market was valued over USD 862 million in 2022 and is forecast to grow at a CAGR of 9.71% through 2028. The growth of the global market for kidney function tests is anticipated to be supported by an increase in awareness of diagnostic techniques for kidney function. The growing global burden of chronic kidney disease is attributed in huge share to diabetes and high blood pressure. In the upcoming years, rising diabetes rates will have an effect on market expansion. The International Diabetes Atlas' tenth edition estimates that 537 million adults (20-79 years old), or one in ten people, had diabetes in 2021. It is anticipated that this number will increase to 643 million by 2030 and 783 million by 2045. Kidneys are among the most vital organs of the human body. Kidneys acts as blood filters, reabsorbing the essential elements and removing the water-soluble waste products from the blood. Hence, they require constant regeneration of dead nephrons and proper blood circulation to maintain healthy cell growth, otherwise they become vulnerable to cancerous tumors and metastasis. The functional damage of the kidney is common across the world and its incidents are increasing at a rapid pace. The symptoms which indicate a problem related to kidneys include high blood pressure, blood in urine, difficulty in urination, frequent urges to urinate, and swelling in the hands and feet due to a buildup of fluids in the body.

Rising Prevalence of Kidney Disorders and Diseases

The growing occurrence of several kidney disorders such as acquired cystic kidney disease, amyloidosis & kidney disease, diabetes insipidus, ectopic kidney, glomerular diseases, anti-GBM (Goodpasture's) disease, IgA nephropathy, among others have drastically increased the number of patients which requires accurate diagnosis and proper treatment. This, in turn, is expected to drive the growth of the global kidney function tests market. Furthermore, acute kidney injury (AKI), also known as acute renal failure or acute kidney injury, is very common in patients who are in hospitals. Acute kidney injury (AKI) affects more than 13 million people and results in 1.7 million deaths every year across the globe. Owing to the rising incidences of kidney diseases and disorders, the demand for early diagnosis and treatments is expected to surge, which bolsters the growth of the market. For instance, according to the Centers for Disease Control and Prevention (CDC), 40% of people with rigorously reduced kidney function are not aware of having chronic kidney disease (CKD).

Technological Advancements

Rising adoption of advanced technology concerning diagnosis and treatment is expected to bolster the growth of the market. These continuous developments and innovations are providing better treatments to patients. The latest trends in technology are using computer-based intelligent decision support systems (DSS) and expert systems, which are used in dialysis and are based on genetic algorithms and artificial neural networks (ANN). Also, the increase in interest in the internet of things (IoT), deep learning, an expanded and complex version of shallow ANN, is being used in the medical field. These advancements help in image diagnosis, alerting systems, and diagnostic assistance.

Increase in the Prevalence of Diabetes and Hypertension

The growing occurrences of underlying conditions such as diabetes and hypertension among the masses have significantly increased the demand for getting diagnoses and treatments done for these chronic diseases. This, in turn, is expected to positively influence the growth of the global kidney function tests market. According to the Centers for Disease Control and Prevention (CDC), in 2019, there are approximately 37.3 million people who have diabetes, accounting for 11.3% of the US population. Out of these, 28.7 million people are diagnosed, and 8.5 million people are undiagnosed. Rising geriatric population is more prone to kidney diseases and kidney failures as aging increases the risk of chronic diseases such as diabetes and hypertension. The increase in the number of elders suffering from diabetes and hypertension is surging the demand for kidney function tests, as kidney disorders and kidney failures are caused by these chronic diseases. Therefore, owing to the rising prevalence of diabetes and hypertension, there is a surge in the number of cases of Chronic Kidney Disease (CKD) and Acute Kidney Injury (AKI), which in turn, is facilitating the growth of the market.

Recent Developments

  • In 2019, Fresenius Medical Care received breakthrough device designation by the U.S. FDA for its most recent hemodialysis machine, whose objective is to stop blood clotting without using any medication
  • Similarly, in 2019, CareDx announced the new model built for kidney transplants. It has included Predicted artificial intelligence (AI) for individuals who are suffering from chronic kidney diseases (CKD).
  • Recently, in 2022, bioMerieux received United States Food and Drug Administration (US FDA) authorization for the innovative VIDAS NEPHROCHECK assay to detect kidney stress in individuals who are at risk of acute kidney injury (AKI).

Market Segmentation

Global kidney function tests market segmentation is based on type, component, end user, regional distribution, and competitional landscape. Based on type, the market is divided into urine tests, blood tests and others. Urine tests are further subcategorized into Urine Protein Tests, Creatinine Clearance Tests, Microalbumin Tests. Blood tests are further categorized into Serum Creatinine Tests, Glomerular Filtration Rate Tests, Blood Urea Nitrogen Tests. Based on component, the market is categorized into Dipsticks, Reagents, Kits & Assays, and Others. Based on end user, the market is further bifurcated into Hospitals & Clinics, Diagnostic Laboratories, and others. In terms of country, the United States is expected to be a lucrative market in the forecast period due to the rising cases of renal disorders.

Market Players

Baxter International Inc., Abbott Laboratories, Inc., Sysmex Corporation., F. Hoffmann-La Roche Ltd., Danaher Corporation., URIT Medical Electronic Co. Ltd., Nova Biomedical Corporation., Laboratory Corporation of America Holdings., Siemens Healthineers., ARKRAY Inc., IDEXX Laboratories, Inc., Fresenius SE & Co. KGaA., Cook Group., ACON Laboratories, Inc, and Randox Laboratories Ltd. are some of the leading companies operating in the market.

Report Scope

In this report, global kidney function tests market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Kidney Function Tests Market, By Type:

Urine Tests

  • Urine Protein Tests
  • Creatinine Clearance Tests
  • Microalbumin Tests

Blood Tests

  • Serum Creatinine Tests
  • Glomerular Filtration Rate Tests
  • Blood Urea Nitrogen Tests

Others

  • Kidney Function Tests Market, By Component:

Dipsticks

Reagents

Kits & Assays

Others

  • Kidney Function Tests Market, By End User:

Hospitals & Clinics

Diagnostic Laboratories

Others

  • Kidney Function Tests Market, By Region:

North America

  • United States
  • Canada
  • Mexico

Europe

  • France
  • Germany
  • United Kingdom
  • Netherlands
  • Sweden
  • Italy
  • Spain

Asia-Pacific

  • China
  • Japan
  • Singapore
  • India
  • South Korea
  • Australia

South America

  • Brazil
  • Argentina
  • Colombia

Middle East & Africa

  • UAE
  • Saudi Arabia
  • South Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Kidney Function Tests market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Voice of Customer

  • 4.1. Prevalence of Kidney Disorders, By Gender
  • 4.2. Prevalence of Kidney Disorders, By Age Group
  • 4.3. Patient's Awareness of Suffering From Chronic Kidney Disorder
  • 4.4. Commonly Observed Kidney Disorders
  • 4.5. Commonly Used Tests for Performing Kidney Function Tests

5. Global Kidney Function Tests Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Urine Tests and Blood Tests)
      • 5.2.1.1. By Urine Tests (Urine Protein Tests, Creatinine Clearance Tests, Microalbumin Tests)
      • 5.2.1.2. By Blood Tests (Serum Creatinine Tests, Glomerular Filtration Rate Tests, Blood Urea Nitrogen Tests)
    • 5.2.2. By Component (Dipsticks, Reagents, Kits & Assays, Others)
    • 5.2.3. By End User (Hospitals & Clinics, Diagnostic Laboratories, Others)
    • 5.2.4. By Region
  • 5.3. Market Map
    • 5.3.1. By Type
    • 5.3.2. By Component
    • 5.3.3. By End User
    • 5.3.4. By Region

6. North America Kidney Function Tests Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Component
    • 6.2.3. By End User
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Kidney Function Tests Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Component
        • 6.3.1.2.3. By End User
    • 6.3.2. Canada Kidney Function Tests Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Component
        • 6.3.2.2.3. By End User
    • 6.3.3. Mexico Kidney Function Tests Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Component
        • 6.3.3.2.3. By End User

7. Europe Kidney Function Tests Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Component
    • 7.2.3. By End User
    • 7.2.4. By Region
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Kidney Function Tests Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Component
        • 7.3.1.2.3. By End User
    • 7.3.2. Germany Kidney Function Tests Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Component
        • 7.3.2.2.3. By End User
    • 7.3.3. United Kingdom Kidney Function Tests Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Component
        • 7.3.3.2.3. By End User
    • 7.3.4. Netherlands Kidney Function Tests Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Component
        • 7.3.4.2.3. By End User
    • 7.3.5. Sweden Kidney Function Tests Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Component
        • 7.3.5.2.3. By End User
    • 7.3.6. Italy Kidney Function Tests Market Outlook
      • 7.3.6.1. Market Size & Forecast
        • 7.3.6.1.1. By Value
      • 7.3.6.2. Market Share & Forecast
        • 7.3.6.2.1. By Type
        • 7.3.6.2.2. By Component
        • 7.3.6.2.3. By End User
    • 7.3.7. Spain Kidney Function Tests Market Outlook
      • 7.3.7.1. Market Size & Forecast
        • 7.3.7.1.1. By Value
      • 7.3.7.2. Market Share & Forecast
        • 7.3.7.2.1. By Type
        • 7.3.7.2.2. By Component
        • 7.3.7.2.3. By End User

8. Asia-Pacific Kidney Function Tests Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Component
    • 8.2.3. By End User
    • 8.2.4. By Region
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Kidney Function Tests Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Component
        • 8.3.1.2.3. By End User
    • 8.3.2. Japan Kidney Function Tests Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Component
        • 8.3.2.2.3. By End User
    • 8.3.3. Singapore Kidney Function Tests Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Component
        • 8.3.3.2.3. By End User
    • 8.3.4. India Kidney Function Tests Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Component
        • 8.3.4.2.3. By End User
    • 8.3.5. South Korea Farming Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Component
        • 8.3.5.2.3. By End User
    • 8.3.6. Australia Farming Market Outlook
      • 8.3.6.1. Market Size & Forecast
        • 8.3.6.1.1. By Value
      • 8.3.6.2. Market Share & Forecast
        • 8.3.6.2.1. By Type
        • 8.3.6.2.2. By Component
        • 8.3.6.2.3. By End User

9. South America Kidney Function Tests Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Component
    • 9.2.3. By End User
    • 9.2.4. By Region
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Kidney Function Tests Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Component
        • 9.3.1.2.3. By End User
    • 9.3.2. Argentina Kidney Function Tests Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Component
        • 9.3.2.2.3. By End User
    • 9.3.3. Colombia Kidney Function Tests Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Component
        • 9.3.3.2.3. By End User

10. Middle East and Africa Kidney Function Tests Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Component
    • 10.2.3. By End User
    • 10.2.4. By Region
  • 10.3. MEA: Country Analysis
    • 10.3.1. UAE Kidney Function Tests Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Component
        • 10.3.1.2.3. By End User
    • 10.3.2. Saudi Arabia Kidney Function Tests Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Component
        • 10.3.2.2.3. By End User
    • 10.3.3. South Africa Kidney Function Tests Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Components
        • 10.3.3.2.3. By End User

11. Market Dynamics

  • 11.1. Drivers
    • 11.1.1. Rising Prevalence of Kidney Disorders and Diseases
    • 11.1.2. Technological Advancements
    • 11.1.3. Increase in the Prevalence of Diabetes and Hypertension
  • 11.2. Challenges
    • 11.2.1. Stringent Regulatory Approvals
    • 11.2.2. Lack of Awareness
    • 11.2.3. False Positive Report

12. Market Trends & Developments

  • 12.1. At-Home Diagnostic Test for Kidney Diseases
  • 12.2. Rise in New Kidney Tests
  • 12.3. Increasing Collaborations

13. Competitive Landscape

  • 13.1. Business Overview
  • 13.2. Product Offerings
  • 13.3. Recent Developments
  • 13.4. Financials (As Reported)
  • 13.5. Key Personnel
  • 13.6. SWOT Analysis
    • 13.6.1. Baxter International Inc
    • 13.6.2. Abbott Laboratories, Inc.
    • 13.6.3. Sysmex Corporation
    • 13.6.4. F. Hoffmann-La Roche Ltd
    • 13.6.5. Danaher Corporation
    • 13.6.6. URIT Medical Electronic Co. Ltd
    • 13.6.7. Nova Biomedical Corporation
    • 13.6.8. Laboratory Corporation of America Holdings
    • 13.6.9. Siemens Healthineers
    • 13.6.10. ARKRAY Inc.
    • 13.6.11. IDEXX Laboratories, Inc
    • 13.6.12. Fresenius SE & Co. KGaA
    • 13.6.13. Cook Group
    • 13.6.14. ACON Laboratories, Inc.
    • 13.6.15. Randox Laboratories Ltd.

14. Strategic Recommendations

List of Figures

List of Figures:

  • Figure 1: Global Kidney Function Tests Market Size, By Value (USD Million), 2018-2028F
  • Figure 2: Global Kidney Function Tests Market Share, By Type, By Value, 2018-2028F
  • Figure 3: Global Kidney Function Tests Market Share, By Urine Test, By Type, 2018-2028F
  • Figure 4: Global Kidney Function Tests Market Share, By Blood Test, By Type, 2018-2028F
  • Figure 5: Global Kidney Function Tests Market Share, By Component, By Value, 2018-2028F
  • Figure 6: Global Kidney Function Tests Market Share, By End User, By Value, 2018-2028F
  • Figure 7: Global Kidney Function Tests Market Share, By Region, By Value, 2018-2028F
  • Figure 8: Global Kidney Function Tests Market Share, By Company, By Value, 2022
  • Figure 9: Global Kidney Function Tests Market Map, By Type, Market Size (USD Million) & Growth Rate (%), 2022
  • Figure 10: Global Kidney Function Tests Market Map, By Urine Test, By Type, Market Size (USD Million) & Growth Rate (%), 2022
  • Figure 11: Global Kidney Function Tests Market Map, By Blood Test, By Type, Market Size (USD Million) & Growth Rate (%), 2022
  • Figure 12: Global Kidney Function Tests Market Map, By Component, Market Size (USD Million) & Growth Rate (%), 2022
  • Figure 13: Global Kidney Function Tests Market Map, By End User, Market Size (USD Million) & Growth Rate (%), 2022
  • Figure 14: Global Kidney Function Tests Market Map, By Region, Market Size (USD Million) & Growth Rate (%), 2022
  • Figure 15: North America Kidney Function Tests Market Size, By Value (USD Million), 2018-2028F
  • Figure 16: North America Kidney Function Tests Market Share, By Type, By Value, 2018-2028F
  • Figure 17: North America Kidney Function Tests Market Share, By Urine Test, By Type, 2018-2028F
  • Figure 18: North America Kidney Function Tests Market Share, By Blood Test, By Type, 2018-2028F
  • Figure 19: North America Kidney Function Tests Market Share, By Component, By Value, 2018-2028F
  • Figure 20: North America Kidney Function Tests Market Share, By End User, By Value, 2018-2028F
  • Figure 21: North America Kidney Function Tests Market Share, By Region, By Value, 2018-2028F
  • Figure 22: United States Kidney Function Tests Market Size, By Value (USD Million), 2018-2028F
  • Figure 23: New Cancer Cases Reported in the United States in 2020, Both Sexes, All Ages
  • Figure 24: United States Kidney Function Tests Market Share, By Type, By Value, 2018-2028F
  • Figure 25: United States Kidney Function Tests Market Share, By Component, By Value, 2018-2028F
  • Figure 26: United States Kidney Function Tests Market Share, By End User, By Value, 2018-2028F
  • Figure 27: Canada Kidney Function Tests Market Size, By Value (USD Million), 2018-2028F
  • Figure 28: Total Health Research Expenditure in Canada (USD), 2017-2021
  • Figure 29: Canada Kidney Function Tests Market Share, By Type, By Value, 2018-2028F
  • Figure 30: Canada Kidney Function Tests Market Share, By Component, By Value, 2018-2028F
  • Figure 31: Canada Kidney Function Tests Market Share, By End User, By Value, 2018-2028F
  • Figure 32: Mexico Kidney Function Tests Market Size, By Value (USD Million), 2018-2028F
  • Figure 33: Number of Kidney Transplants Performed in Mexico from 2018 to 2021(in 1,000s)
  • Figure 34: Mexico Kidney Function Tests Market Share, By Type, By Value, 2018-2028F
  • Figure 35: Mexico Kidney Function Tests Market Share, By Component, By Value, 2018-2028F
  • Figure 36: Mexico Kidney Function Tests Market Share, By End User, By Value, 2018-2028F
  • Figure 37: Europe Kidney Function Tests Market Size, By Value (USD Million), 2018-2028F
  • Figure 38: Europe Kidney Function Tests Market Share, By Type, By Value, 2018-2028F
  • Figure 39: Europe Kidney Function Tests Market Share, By Urine Test, By Type, 2018-2028F
  • Figure 40: Europe Kidney Function Tests Market Share, By Blood Test, By Type, 2018-2028F
  • Figure 41: Europe Kidney Function Tests Market Share, By Component, By Value, 2018-2028F
  • Figure 42: Europe Kidney Function Tests Market Share, By End User, By Value, 2018-2028F
  • Figure 43: Europe Kidney Function Tests Market Share, By Region, By Value, 2018-2028F
  • Figure 44: France Kidney Function Tests Market Size, By Value (USD Million), 2018-2028F
  • Figure 45: Percentage of New Cancer Cases in France, Both Sexes, All Ages, 2020
  • Figure 46: France Kidney Function Tests Market Share, By Type, By Value, 2018-2028F
  • Figure 47: France Kidney Function Tests Market Share, By Component, By Value, 2018-2028F
  • Figure 48: France Kidney Function Tests Market Share, By End User, By Value, 2018-2028F
  • Figure 49: Germany Kidney Function Tests Market Size, By Value (USD Million), 2018-2028F
  • Figure 50: Germany Research & Development Expenditure as a Percentage of GDP
  • Figure 51: Germany Kidney Function Tests Market Share, By Type, By Value, 2018-2028F
  • Figure 52: Germany Kidney Function Tests Market Share, By Component, By Value, 2018-2028F
  • Figure 53: Germany Kidney Function Tests Market Share, By End User, By Value, 2018-2028F
  • Figure 54: United Kingdom Kidney Function Tests Market Size, By Value (USD Million), 2018-2028F
  • Figure 55: Annual Expenditure on Health in United Kingdom (USD Million), 2017-2021
  • Figure 56: United Kingdom Kidney Function Tests Market Share, By Type, By Value, 2018-2028F
  • Figure 57: United Kingdom Kidney Function Tests Market Share, By Component, By Value, 2018-2028F
  • Figure 58: United Kingdom Kidney Function Tests Market Share, By End User, By Value, 2018-2028F
  • Figure 59: Netherlands Kidney Function Tests Market Size, By Value (USD Million), 2018-2028F
  • Figure 60: Total Number of Patients on the Kidney Transplant Waiting List in the Netherlands from 2019 to 2021
  • Figure 61: Netherlands Kidney Function Tests Market Share, By Type, By Value, 2018-2028F
  • Figure 62: Netherlands Kidney Function Tests Market Share, By Component, By Value, 2018-2028F
  • Figure 63: Netherlands Kidney Function Tests Market Share, By End User, By Value, 2018-2028F
  • Figure 64: Sweden Kidney Function Tests Market Size, By Value (USD Million), 2018-2028F
  • Figure 65: Rate of Kidney Transplantation Activity Per Million Population in Sweden from 2019 to 2021
  • Figure 66: Sweden Kidney Function Tests Market Share, By Type, By Value, 2018-2028F
  • Figure 67: Sweden Kidney Function Tests Market Share, By Component, By Value, 2018-2028F
  • Figure 68: Sweden Kidney Function Tests Market Share, By End User, By Value, 2018-2028F
  • Figure 69: Italy Kidney Function Tests Market Size, By Value (USD Million), 2018-2028F
  • Figure 70: Number of Individuals Suffering from Diabetes in Italy, 2017-2020 (In Thousands)
  • Figure 71: Italy Kidney Function Tests Market Share, By Type, By Value, 2018-2028F
  • Figure 72: Italy Kidney Function Tests Market Share, By Component, By Value, 2018-2028F
  • Figure 73: Italy Kidney Function Tests Market Share, By End User, By Value, 2018-2028F
  • Figure 74: Spain Kidney Function Tests Market Size, By Value (USD Million), 2018-2028F
  • Figure 75: Percentage of New Cancer Cases in Spain, By Cancer Site, 2020
  • Figure 76: Spain Kidney Function Tests Market Share, By Type, By Value, 2018-2028F
  • Figure 77: Spain Kidney Function Tests Market Share, By Component, By Value, 2018-2028F
  • Figure 78: Spain Kidney Function Tests Market Share, By End User, By Value, 2018-2028F
  • Figure 79: Asia-Pacific Kidney Function Tests Market Size, By Value (USD Million), 2018-2028F
  • Figure 80: Asia-Pacific Kidney Function Tests Market Share, By Type, By Value, 2018-2028F
  • Figure 81: Asia-Pacific Kidney Function Tests Market Share, By Urine Test, By Type, 2018-2028F
  • Figure 82: Asia-Pacific Kidney Function Tests Market Share, By Blood Test, By Type, 2018-2028F
  • Figure 83: Asia-Pacific Kidney Function Tests Market Share, By Component, By Value, 2018-2028F
  • Figure 84: Asia-Pacific Kidney Function Tests Market Share, By End User, By Value, 2018-2028F
  • Figure 85: Asia-Pacific Kidney Function Tests Market Share, By Region, By Value, 2018-2028F
  • Figure 86: China Kidney Function Tests Market Size, By Value (USD Million), 2018-2028F
  • Figure 87: Percentage of New Cancer Cases in China, Both Sexes, All Ages, 2020
  • Figure 88: China Kidney Function Tests Market Share, By Type, By Value, 2018-2028F
  • Figure 89: China Kidney Function Tests Market Share, By Component, By Value, 2018-2028F
  • Figure 90: China Kidney Function Tests Market Share, By End User, By Value, 2018-2028F
  • Figure 91: Japan Kidney Function Tests Market Size, By Value (USD Million), 2018-2028F
  • Figure 92: Japan Research & Development Expenditure as a Percentage of GDP, 2017-2020
  • Figure 93: Japan Kidney Function Tests Market Share, By Type, By Value, 2018-2028F
  • Figure 94: Japan Kidney Function Tests Market Share, By Component, By Value, 2018-2028F
  • Figure 95: Japan Kidney Function Tests Market Share, By End User, By Value, 2018-2028F
  • Figure 96: Singapore Kidney Function Tests Market Size, By Value (USD Million), 2018-2028F
  • Figure 97: Prevalence of Diseases in Singapore
  • Figure 98: Singapore Kidney Function Tests Market Share, By Type, By Value, 2018-2028F
  • Figure 99: Singapore Kidney Function Tests Market Share, By Component, By Value, 2018-2028F
  • Figure 100: Singapore Kidney Function Tests Market Share, By End User, By Value, 2018-2028F
  • Figure 101: India Kidney Function Tests Market Size, By Value (USD Million), 2018-2028F
  • Figure 102: Share of Respondents with Diabetes across India (%), 2018-2021
  • Figure 103: India Kidney Function Tests Market Share, By Type, By Value, 2018-2028F
  • Figure 104: India Kidney Function Tests Market Share, By Component, By Value, 2018-2028F
  • Figure 105: India Kidney Function Tests Market Share, By End User, By Value, 2018-2028F
  • Figure 106: South Korea Kidney Function Tests Market Size, By Value (USD Million), 2018-2028F
  • Figure 107: Percentage of New Cancer Cases in South Korea, Both Sexes, All Ages, 2020
  • Figure 108: South Korea Kidney Function Tests Market Share, By Type, By Value, 2018-2028F
  • Figure 109: South Korea Kidney Function Tests Market Share, By Component, By Value, 2018-2028F
  • Figure 110: South Korea Kidney Function Tests Market Share, By End User, By Value, 2018-2028F
  • Figure 111: Australia Kidney Function Tests Market Size, By Value (USD Million), 2018-2028F
  • Figure 112: Australia Diabetes Estimates in People of Age Group 20-79 Years (in Thousands)
  • Figure 113: Australia Kidney Function Tests Market Share, By Type, By Value, 2018-2028F
  • Figure 114: Australia Kidney Function Tests Market Share, By Component, By Value, 2018-2028F
  • Figure 115: Australia Kidney Function Tests Market Share, By End User, By Value, 2018-2028F
  • Figure 116: South America Kidney Function Tests Market Size, By Value (USD Million), 2018-2028F
  • Figure 117: South America Kidney Function Tests Market Share, By Type, By Value, 2018-2028F
  • Figure 118: South America Kidney Function Tests Market Share, By Urine Test, By Type, 2018-2028F
  • Figure 119: South America Kidney Function Tests Market Share, By Blood Test, By Type, 2018-2028F
  • Figure 120: South America Kidney Function Tests Market Share, By Component, By Value, 2018-2028F
  • Figure 121: South America Kidney Function Tests Market Share, By End User, By Value, 2018-2028F
  • Figure 122: South America Kidney Function Tests Market Share, By Region, By Value, 2018-2028F
  • Figure 123: Brazil Kidney Function Tests Market Size, By Value (USD Million), 2018-2028F
  • Figure 124: Governmental Health Expenditure in Brazil in 2021, By Area, (Square Unit)
  • Figure 125: Brazil Kidney Function Tests Market Share, By Type, By Value, 2018-2028F
  • Figure 126: Brazil Kidney Function Tests Market Share, By Component, By Value, 2018-2028F
  • Figure 127: Brazil Kidney Function Tests Market Share, By End User, By Value, 2018-2028F
  • Figure 128: Argentina Kidney Function Tests Market Size, By Value (USD Million), 2018-2028F
  • Figure 129: Percentage of New Cancer Cases in Argentina, Both Sexes, All Ages, 2020
  • Figure 130: Argentina Kidney Function Tests Market Share, By Type, By Value, 2018-2028F
  • Figure 131: Argentina Kidney Function Tests Market Share, By Component, By Value, 2018-2028F
  • Figure 132: Argentina Kidney Function Tests Market Share, By End User, By Value, 2018-2028F
  • Figure 133: Colombia Kidney Function Tests Market Size, By Value (USD Million), 2018-2028F
  • Figure 134: Percentage of New Cancer Cases in Colombia, Both Sexes, All Ages, 2020
  • Figure135: Colombia Kidney Function Tests Market Share, By Type, By Value, 2018-2028F
  • Figure 136: Colombia Kidney Function Tests Market Share, By Component, By Value, 2018-2028F
  • Figure 137: Colombia Kidney Function Tests Market Share, By End User, By Value, 2018-2028F
  • Figure 138: Middle East & Africa Kidney Function Tests Market Size, By Value (USD Million), 2018-2028F
  • Figure 139: Middle East & Africa Kidney Function Tests Market Share, By Type, By Value, 2018-2028F
  • Figure 140: Middle East & Africa Kidney Function Tests Market Share, By Urine Test, By Type, 2018-2028F
  • Figure 141: Middle East & Africa Kidney Function Tests Market Share, By Blood Test, By Type, 2018-2028F
  • Figure 142: Middle East & Africa Kidney Function Tests Market Share, By Component, By Value, 2018-2028F
  • Figure 143: Middle East & Africa Kidney Function Tests Market Share, By End User, By Value, 2018-2028F
  • Figure 144: Middle East & Africa Kidney Function Tests Market Share, By Region, By Value, 2018-2028F
  • Figure 145: UAE Kidney Function Tests Market Size, By Value (USD Million), 2018-2028F
  • Figure 146: Outpatient Healthcare Expenditure in UAE (USD Billion), 2017-2022
  • Figure 147: UAE Kidney Function Tests Market Share, By Type, By Value, 2018-2028F
  • Figure 148: UAE Kidney Function Tests Market Share, By Component, By Value, 2018-2028F
  • Figure 149: UAE Kidney Function Tests Market Share, By End User, By Value, 2018-2028F
  • Figure 150: Saudi Arabia Kidney Function Tests Market Size, By Value (USD Million), 2018-2028F
  • Figure 151: Percentage of New Cancer Cases in Saudi Arabia, Both Sexes, All Ages, 2020
  • Figure 152: Saudi Arabia Kidney Function Tests Market Share, By Type, By Value, 2018-2028F
  • Figure 153: Saudi Arabia Kidney Function Tests Market Share, By Component, By Value, 2018-2028F
  • Figure 154: Saudi Arabia Kidney Function Tests Market Share, By End User, By Value, 2018-2028F
  • Figure 155: South Africa Kidney Function Tests Market Size, By Value (USD Million), 2018-2028F
  • Figure 156: Percentage of New Cancer Cases in South Africa, Both Sexes, All Ages, 2020
  • Figure 157: South Africa Kidney Function Tests Market Share, By Type, By Value, 2018-2028F
  • Figure 158: South Africa Kidney Function Tests Market Share, By Component, By Value, 2018-2028F
  • Figure 159: South Africa Kidney Function Tests Market Share, By End User, By Value, 2018-2028F